Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Riken Vitamin Co., Ltd. ( (JP:4526) ) has shared an announcement.
Riken Vitamin Co., Ltd. has reported the latest progress of its share buyback program authorized by its board on April 30, 2025, under which it is repurchasing common stock on the Tokyo Stock Exchange. During the period from December 1 to December 31, 2025, the company acquired 61,600 shares for a total of 178,019,591 yen, bringing cumulative repurchases as of December 31, 2025, to 523,700 shares at a total cost of 1,474,531,634 yen, against an authorized ceiling of 1,000,000 shares or 2 billion yen to be executed by March 24, 2026, indicating ongoing efforts to enhance capital efficiency and shareholder returns through treasury stock acquisition.
The most recent analyst rating on (JP:4526) stock is a Buy with a Yen3244.00 price target. To see the full list of analyst forecasts on Riken Vitamin Co., Ltd. stock, see the JP:4526 Stock Forecast page.
More about Riken Vitamin Co., Ltd.
Riken Vitamin Co., Ltd. is a Japanese manufacturer listed on the Tokyo Stock Exchange Prime Market under securities code 4526, operating in the food and chemical-related sectors with a focus on value-added ingredients such as vitamins and related products for domestic and international markets.
Average Trading Volume: 68,844
Technical Sentiment Signal: Buy
Current Market Cap: Yen67.66B
See more insights into 4526 stock on TipRanks’ Stock Analysis page.